| Authors: |
Oh J; Division of Neurology, Department of Medicine, St Michael's Hospital, University of Toronto, Toronto, Canada. Electronic address: jiwon.oh@unityhealth.to., Bar-Or A; Center for Neuroinflammation and Experimental Therapeutics and Division of multiple sclerosis and Related Disorders, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Montalban X; Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d'Hebron, Barcelona, Spain., Sormani MP; Dipartimento di Scienze della Salute, Università degli Studi di Genova, Genoa, Italy., Weber MS; Department of Neurology, University Medical Centre Göttingen, Göttingen, Germany; Institute of Neuropathology, University Medical Centre Göttingen, Göttingen, Germany; Department of Translational Neuroinflammation and Automated Microscopy, Fraunhofer-Institute for Translational Medicine and Pharmacology (ITMP), Göttingen, Germany., Reich DS; Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA. |
